Oslo, 4 February 2025: Board member Kathrine Elisabeth Gamborg Andreassen has
informed the board of directors of Observe Medical ASA (the "Company" or
"Observe Medical") that she will resign from the Company's board of directors,
effective 5 February 2025, in order to focus on her responsibilities as CEO of
Navamedic ASA.

Following the resignation, the board of directors will continue to constitute a
quorum and is comprised of Terje Bakken (chair), Eskild Endrerud (board member)
and Line Tønnessen (board member).

The appointment of any replacement director is expected to be considered in
relation to the Company's annual general meeting on 28 May 2025 (the "AGM"). Ms.
Gamborg Andreassen has also informed that she has offered herself for election
to the Company's nomination committee at the AGM.

For further information, please contact:

Jørgen Mann

CEO

Observe Medical

Mobile: +45 408 67 558

E-mail: jorgen.mann@observemedical.com

Johan Fagerli

CFO

Observe Medical

Mobile: +47 958 12 765

E-mail: johan.fagerli@observemedical.com

This information is subject to the disclosure requirements pursuant to article
19 of the EU Market Abuse Regulation and section 5-12 of the Norwegian
Securities Trading Act.

About Observe Medical:

Observe Medical is a Nordic medtech company that develops, markets, and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data
accuracy, and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement and ultrasound, in combination with targeted M&A and
distribution. Observe Medical is working with a network of leading distributors
to provide outstanding solutions for healthcare professionals globally.

The Company is headquartered in Oslo, Norway.

Further information is available at www.observemedical.com.